glp 1 news GLP-1 receptor agonists show promise in treating substance use disorders Alarming rise in weight loss

These changes occur quickly so its not a long-time horizon to realize these benefits (from a sheer cost perspective). Obesity: A Dynamic Endocrine Issue In June 2013, the American Medical Association acknowledged obesity as a disease, writing in its resolution, The suggestion that obesity is not a disease but rather a consequence of a chosen lifestyle exemplified by overeating and/or inactivity is equivalent to suggesting that lung cancer is not a disease because it was brought about by individual choice to smoke cigarettes. Ten years later, and theres much more work to do

This combination approach gives patients the best chance of long-term success

I had anticipated that many patients would not want to start an injectable medication, but this has not been a barrier for most of my patients, and the availability of a medication that can be injected once weekly has made it possible for more patients to agree to try, she says

The short answer: You can begin with your primary care clinician, a specialist in obesity medicine, or in some cases a telehealth provider